1. Project Overview

        BIO Protocol is a decentralized platform designed to revolutionize science funding and biotech innovation. It empowers global communities—including patients, scientists, and biotech investors—to collaboratively fund, develop, and own tokenized biotech projects and intellectual property (IP). By bridging decentralized science (DeSci) with biotechnology, BIO Protocol unlocks new opportunities for innovation and expands access to science funding.

2. Token Information 

  • Token Name: $BIO

  • Token Type: ERC20

  • Initial Supply: 1,296,529,168 (39.05% of total supply)

  • Total Supply: 3,320,000,000

3. Project Highlights

  • Decentralized Funding: Empowers individuals to invest in groundbreaking biotech projects, democratizing access to innovation.

  • Capital Efficiency: Combines resources such as patient data, capital, and labor to reduce the costs associated with biotech advancements.

  • Diversified Portfolio: Bundles biotech projects into a single portfolio, mitigating investment risks through diversification.

  • Global Talent & Capital Pool: Connects scientists, researchers, and investors from around the world, allowing them to contribute expertise or funding to specific therapeutic areas or drug development.

  • Shared IP Ownership: Facilitates co-ownership of Biotech DAOs and scientific intellectual property through tokenization.

  • Liquid Markets: Creates opportunities for early liquidity in traditionally illiquid biotech assets.

  • Open Access: Breaks down barriers in scientific funding and decision-making, fostering inclusivity and collaboration.

4. Token Utility

  • Governance & Decentralization: The BIO token empowers holders with governance rights within the BIO Protocol and meta-governance capabilities across BioDAOs within the network.

  • Whitelisted Access: BIO token holders gain exclusive, whitelisted access to BioDAO funding rounds and tokenized intellectual property (IP) available on the network.

  • Curation: Through the BIO Launchpad, token holders decide which BioDAOs are launched and receive network-backed support, including funding and liquidity.

  • Network BioDAOs: BIO serves as a portfolio of DeSci tokens, with BioDAOs in the network contributing a portion of their initial token supply to the protocol in return for funding, liquidity, and acceleration services.

  • Protocol-Owned Liquidity: The BIO Protocol manages liquidity using BioDAO tokens and IP-Tokens in its treasury, generating revenue from trading fees through its protocol-owned liquidity (POL) model.